8-K

Company

KIORA PHARMACEUTICALS INC

Filed

July 20, 2023

Period of Report

July 18, 2023

Accession Number

0001372514-23-000107

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →